(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MAGED2 mRNA] CTD PMID:31150632 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of MAGED2 mRNA CTD PMID:15834898 , PMID:17557909 17alpha-ethynylestradiol affects expression ISO RGD:737563 6480464 Ethinyl Estradiol affects the expression of MAGED2 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of MAGED2 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO RGD:734427 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of MAGED2 mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:737563 6480464 Estradiol results in decreased expression of MAGED2 mRNA CTD PMID:30077407 17beta-estradiol multiple interactions ISO RGD:737563 6480464 [Polyphenols co-treated with Estradiol] results in increased expression of MAGED2 mRNA CTD PMID:30077407 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:734427 6480464 Metribolone results in increased expression of MAGED2 mRNA CTD PMID:17010196 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737563 6480464 Tetrachlorodibenzodioxin affects the expression of MAGED2 mRNA CTD PMID:18343893 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737563 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAGED2 mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737563 6480464 AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of MAGED2 mRNA] CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737563 6480464 Tetrachlorodibenzodioxin results in increased expression of MAGED2 mRNA CTD PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:737563 6480464 2 more ... CTD PMID:18343893 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:734427 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAGED2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:737563 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MAGED2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:737563 6480464 Fenretinide results in decreased expression of MAGED2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MAGED2 mRNA CTD PMID:24780913 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAGED2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of MAGED2 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:734427 6480464 Antirheumatic Agents results in increased expression of MAGED2 mRNA CTD PMID:24449571 avobenzone increases expression ISO RGD:734427 6480464 avobenzone results in increased expression of MAGED2 mRNA CTD PMID:31016361 benzo[a]pyrene multiple interactions ISO RGD:737563 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of MAGED2 mRNA] CTD PMID:15034205 benzo[a]pyrene decreases expression ISO RGD:737563 6480464 Benzo(a)pyrene results in decreased expression of MAGED2 mRNA CTD PMID:15034205 , PMID:20713471 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MAGED2 mRNA CTD PMID:18164116 bisphenol A increases expression ISO RGD:734427 6480464 bisphenol A results in increased expression of MAGED2 mRNA CTD PMID:20678512 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAGED2 mRNA CTD PMID:30816183 bisphenol A decreases methylation ISO RGD:737563 6480464 bisphenol A results in decreased methylation of MAGED2 promoter CTD PMID:27312807 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAGED2 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of MAGED2 mRNA CTD PMID:26496021 bisphenol F multiple interactions ISO RGD:734427 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAGED2 mRNA CTD PMID:28628672 carbon nanotube decreases expression ISO RGD:737563 6480464 Nanotubes, Carbon analog results in decreased expression of MAGED2 mRNA, Nanotubes, Carbon results in decreased expression of MAGED2 mRNA CTD PMID:25620056 choline multiple interactions ISO RGD:737563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAGED2 mRNA CTD PMID:20938992 cisplatin affects response to substance ISO RGD:734427 6480464 MAGED2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin multiple interactions ISO RGD:734427 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MAGED2 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:734427 6480464 Cisplatin results in increased expression of MAGED2 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:734427 6480464 cobaltous chloride results in decreased expression of MAGED2 mRNA CTD PMID:19320972 , PMID:19376846 copper(II) sulfate decreases expression ISO RGD:734427 6480464 Copper Sulfate results in decreased expression of MAGED2 mRNA CTD PMID:19549813 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of MAGED2 mRNA CTD PMID:15755911 coumestrol decreases expression ISO RGD:734427 6480464 Coumestrol results in decreased expression of MAGED2 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:737563 6480464 Cyclosporine results in decreased expression of MAGED2 mRNA CTD PMID:19770486 cyclosporin A decreases methylation ISO RGD:734427 6480464 Cyclosporine results in decreased methylation of MAGED2 promoter CTD PMID:27989131 dexamethasone multiple interactions ISO RGD:734427 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAGED2 mRNA CTD PMID:28628672 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MAGED2 mRNA CTD PMID:25152437 doxorubicin increases expression ISO RGD:734427 6480464 Doxorubicin results in increased expression of MAGED2 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:734427 6480464 Selenium results in increased expression of MAGED2 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAGED2 mRNA CTD PMID:29391264 ethyl methanesulfonate increases expression ISO RGD:734427 6480464 Ethyl Methanesulfonate results in increased expression of MAGED2 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:737563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAGED2 mRNA CTD PMID:20938992 formaldehyde increases expression ISO RGD:734427 6480464 Formaldehyde results in increased expression of MAGED2 mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of MAGED2 mRNA CTD PMID:25539665 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of MAGED2 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:734427 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAGED2 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:737563 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAGED2 mRNA CTD PMID:20938992 lithium chloride decreases expression ISO RGD:734427 6480464 Lithium Chloride results in decreased expression of MAGED2 mRNA CTD PMID:23527032 manganese atom decreases expression ISO RGD:737563 6480464 Manganese results in decreased expression of MAGED2 mRNA CTD PMID:23499988 manganese(0) decreases expression ISO RGD:737563 6480464 Manganese results in decreased expression of MAGED2 mRNA CTD PMID:23499988 methyl methanesulfonate increases expression ISO RGD:734427 6480464 Methyl Methanesulfonate results in increased expression of MAGED2 mRNA CTD PMID:23649840 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MAGED2 mRNA CTD PMID:18164116 N-nitrosodiethylamine multiple interactions ISO RGD:737563 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of MAGED2 gene CTD PMID:23968726 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAGED2 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:737563 6480464 Acetaminophen affects the expression of MAGED2 mRNA CTD PMID:17562736 phenobarbital multiple interactions ISO RGD:737563 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MAGED2 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:737563 6480464 Phenobarbital results in increased expression of MAGED2 mRNA CTD PMID:19482888 piperonyl butoxide multiple interactions ISO RGD:737563 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of MAGED2 gene CTD PMID:23968726 pirinixic acid increases expression ISO RGD:737563 6480464 pirinixic acid results in increased expression of MAGED2 mRNA CTD PMID:23811191 selenium atom increases expression ISO RGD:734427 6480464 Selenium results in increased expression of MAGED2 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:734427 6480464 Silicon Dioxide analog results in decreased expression of MAGED2 mRNA CTD PMID:25895662 sunitinib decreases expression ISO RGD:734427 6480464 Sunitinib results in decreased expression of MAGED2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:737563 6480464 Tamoxifen affects the expression of MAGED2 mRNA CTD PMID:17555576 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MAGED2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MAGED2 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAGED2 mRNA CTD PMID:23411599 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAGED2 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of MAGED2 mRNA CTD PMID:25729387 valproic acid affects expression ISO RGD:737563 6480464 Valproic Acid affects the expression of MAGED2 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:734427 6480464 Valproic Acid results in decreased expression of MAGED2 mRNA CTD PMID:23179753 , PMID:28001369 valproic acid affects expression ISO RGD:734427 6480464 Valproic Acid affects the expression of MAGED2 mRNA CTD PMID:25979313 vitamin E increases expression ISO RGD:734427 6480464 Vitamin E results in increased expression of MAGED2 mRNA CTD PMID:19244175
Biological Process female pregnancy ISO RGD:734427 1624291 (PMID:27120771) RGD PMID:27120771 renal sodium ion absorption ISO RGD:734427 1624291 (PMID:27120771) RGD PMID:27120771 Cellular Component cytosol IEA UniProtKB:A0A024R9Y7 , ensembl:ENSP000003641931600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytosol ISO RGD:734427 1624291 RGD GO_REF:0000052 cytosol IEA UniProtKB:Q9UNF1 , ensembl:ENSP000003641931600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleolus IEA UniProtKB:A0A024R9Y7 , ensembl:ENSP000003641931600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleolus ISO RGD:734427 1624291 RGD GO_REF:0000052 nucleolus IEA UniProtKB:Q9UNF1 , ensembl:ENSP000003641931600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleoplasm ISO RGD:734427 1624291 RGD GO_REF:0000052 nucleoplasm IEA UniProtKB:Q9UNF1 , ensembl:ENSP000003641931600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleoplasm IEA UniProtKB:A0A024R9Y7 , ensembl:ENSP000003641931600115 GO_REF:0000107 Ensembl GO_REF:0000107 Molecular Function protein binding ISO RGD:734427 1624291 UniProtKB:P25685 more ... RGD PMID:25852190 , PMID:27120771
Gene-Chemical Interaction Annotations
